The Nephron journals/Nephron journals · 2001 · 56 citations · 13 references
MedicineEndocrinologyInternal MedicineDiabetologyRenal PathologyRenal PathophysiologyDiabetes MellitusDiabetic NephropathyRenal DiseaseRenal Function TestsUrinary ExcretionCreatinine-based BiomarkersDiabetes Mellitus PathophysiologyDiabetes-related ComplicationsRenal Function CovariatesType 2 Diabetes Mellitus Pathogenesis
OBJECTIVE: Circulating levels of lipocalin-type prostaglandin D synthase (L-PGDS)/beta-trace reportedly increase in renal failure as well as in cardiovascular injuries. We investigated the alterations of L-PGDS in urine and plasma in the early stage of type-2 diabetic patients. METHOD: Thirty-six type-2 diabetic patients and 29 normal subjects were studied. Overnight spot urine and plasma samples were obtained in the morning. L-PGDS was measured by ELISA method using anti-L-PGDS antibody. Variables indicating renal function were determined. RESULTS: Plasma L-PGDS concentration was slightly higher in the patients with diabetes mellitus than in the control subjects, whereas the urinary L-PGDS excretion almost doubled in the diabetic patients as compared with that in the control subjects. Plasma L-PGDS was determined by plasma creatinine (Cr) concentration while urinary L-PGDS excretion was correlated solely with urinary protein excretion. There was no relationship between plasma L-PGDS concentration and urinary L-PGDS excretion. The averaged plasma concentration of L-PGDS in the diabetics with a normal Cr level in plasma, corresponding to that in the controls, was determined by the plasma Cr concentration. On the other hand, the urinary L-PGDS excretion was determined by the amount of proteinuria and greater in the diabetics with a normal Cr level in plasma than in the controls even when the patients exhibited urinary protein excretion equal to that in the control subjects. CONCLUSIONS: Urinary L-PGDS excretion increased in the early stage of kidney injury in patients with type-2 diabetes mellitus. The urinary excretion was correlated independently with urinary protein excretion even when there was no difference in urinary protein or albumin excretions, thereby suggesting that urinary L-PGDS excretion is possibly a more sensitive indicator of renal injuries than proteinuria. Urinary L-PGDS may thus predict the progression of renal injuries in diabetic patients.
13
The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
Mercedes Ricote, Andrew C. Li, Timothy M. Willson et al. · Nature · 1998 · 3.5K citations
Knut Borch‐Johnsen, Bo Feldt‐Rasmussen, Svend Strandgaard et al. · Arteriosclerosis Thrombosis and Vascular Biology · 1999 · 438 citations
Agnes Jager, Piet J. Kostense, Henricus G. Ruhé et al. · Arteriosclerosis Thrombosis and Vascular Biology · 1999 · 362 citations · Full text